CX Securities has divested majority of its investment in Natco Pharma, over a period of time, by selling the equity shares in the open market through the stock exchanges. The entity had invested in the Company by acquiring 17 lakh equity shares of Rs 10 each, which were allotted on preferential basis on November 29, 2013.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
